ClinicalTrialsFinder

Non-squamous EGFR Wt NSCLC Clinical Trials in Buffalo, New York

1 recruitingBuffalo, New York

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Ovarian CancerEndometrial CancerOvarian Cancer Metastatic+4 more
Whitehawk Therapeutics, Inc.226 enrolled12 locationsNCT07444814